NASDAQ : GOSS
Gossamer Bio, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 10.38 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 63.49M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Gossamer Bio, Inc. (GOSS) reported revenue of 53.29M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 53.29M | 48.47M | 114.70M | |||
| Gross Profit | 53.29M | 48.47M | 114.70M | |||
| Selling, General & Admin | 47.94M | 37.63M | 36.13M | 38.45M | 47.61M | 45.78M |
| Research & Development | 163.96M | 174.09M | 138.49M | 135.30M | 170.92M | 170.27M |
| Operating Expenses | 211.90M | 211.72M | 174.62M | 173.76M | 218.53M | 216.05M |
| Operating Income | -158.62M | -163.25M | -59.92M | -173.76M | -218.53M | -216.05M |
| Interest Expense | -10.96M | -10.99M | -11.52M | -13.51M | -13.88M | -19.44M |
| Interest & Investment Income | 1.76M | 1.97M | 1.78M | 2.00M | 1.58M | 761.00K |
| Other Non Operating Income (Expenses) | 261.00K | 3.41M | 960.00K | 6.01M | 107.00K | 1.14M |
| EBT Excluding Unusual Items | -167.56M | -168.86M | -68.70M | -179.27M | -230.72M | -233.59M |
| Gain (Loss) on Sale of Investments | 7.28M | 7.28M | 13.06M | 9.45M | 1.41M | -339.00K |
| Other Unusual Items | 42.45M | -1.40M | ||||
| Pretax Income | -125.31M | -170.46M | -55.63M | -179.82M | -229.38M | -234.00M |
| Income Tax Expense | -88.00K | -88.00K | 893.00K | |||
| Net Income | -125.22M | -170.37M | -56.53M | -179.82M | -229.38M | -234.00M |
| Net Income to Common | -125.22M | -170.37M | -56.53M | -179.82M | -229.38M | -234.00M |
| Shares Outstanding (Basic) | 3.17M | 2.86M | 2.83M | 1.91M | 1.06M | 935.54K |
| Shares Outstanding (Diluted) | 3.17M | 2.86M | 2.83M | 1.91M | 1.06M | 935.54K |
| EPS (Basic) | -39.49 | -59.64 | -19.99 | -94.26 | -216.97 | -250.13 |
| EPS (Diluted) | -51.97 | -59.64 | -19.99 | -94.26 | -216.97 | -250.13 |
| Free Cash Flow | -162.63M | -171.34M | -3.47M | -159.16M | -187.44M | -190.44M |
| Free Cash Flow Per Share | -51.29 | -59.98 | -1.23 | -83.43 | -177.30 | -203.56 |
| Gross Margin | 100.00% | 100.00% | 100.00% | |||
| Operating Margin | -297.67% | -336.81% | -52.24% | |||
| Profit Margin | -235.00% | -351.49% | -49.28% | |||
| Free Cash Flow Margin | -305.19% | -353.50% | -3.02% | |||
| EBITDA | -158.60M | -163.23M | -59.09M | -172.15M | -216.70M | -214.31M |
| EBITDA Margin | -297.63% | -51.51% | ||||
| D&A For EBITDA | 21.00K | 24.00K | 833.00K | 1.61M | 1.83M | 1.74M |
| EBIT | -158.62M | -163.25M | -59.92M | -173.76M | -218.53M | -216.05M |
| EBIT Margin | -297.67% | -52.24% | ||||
| Revenue as Reported | 53.29M | 48.47M | 114.70M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 41.15M | 37.73M | 46.07M | 32.11M | 111.97M | 183.40M |
| Short-Term Investments | 15.88M | 99.20M | 248.44M | 264.32M | 143.71M | 141.81M |
| Cash & Short-Term Investments | 57.03M | 136.93M | 294.52M | 296.43M | 255.68M | 325.22M |
| Accounts Receivable | 6.11M | 12.23M | 5.34M | |||
| Other Receivables | 300.00K | 200.00K | 200.00K | |||
| Receivables | 6.11M | 12.53M | 5.54M | 200.00K | ||
| Prepaid Expenses | 9.59M | 18.18M | 9.83M | 10.09M | 6.20M | 6.30M |
| Restricted Cash | 64.00K | |||||
| Total Current Assets | 72.72M | 167.64M | 309.89M | 306.52M | 261.88M | 331.78M |
| Property, Plant & Equipment | 3.71M | 4.20M | 5.12M | 4.78M | 9.89M | 10.80M |
| Other Long-Term Assets | 429.00K | 408.00K | 283.00K | 618.00K | 680.00K | 1.08M |
| Total Assets | 76.87M | 172.25M | 315.29M | 311.92M | 272.45M | 343.66M |
| Accounts Payable | 5.95M | 5.96M | 2.32M | 5.53M | 1.46M | 3.24M |
| Accrued Expenses | 26.42M | 36.55M | 24.68M | 31.16M | 33.17M | 31.34M |
| Current Portion of Long-Term Debt | 36.15M | 11.61M | 11.61M | |||
| Current Portion of Leases | 965.00K | 938.00K | 961.00K | 3.30M | 2.98M | 2.90M |
| Current Income Taxes Payable | 6.00K | 6.00K | ||||
| Current Unearned Revenue | 7.07M | 19.99M | 17.05M | |||
| Other Current Liabilities | 61.23M | 2.38M | ||||
| Total Current Liabilities | 137.78M | 63.44M | 45.01M | 51.60M | 49.23M | 39.86M |
| Long-Term Debt | 198.51M | 197.52M | 197.41M | 207.70M | 179.12M | |
| Long-Term Leases | 2.96M | 3.46M | 4.40M | 144.00K | 3.45M | 3.22M |
| Long-Term Unearned Revenue | 30.16M | 29.61M | 38.87M | |||
| Total Liabilities | 170.90M | 295.01M | 285.80M | 249.15M | 260.37M | 222.19M |
| Common Stock | 50.00K | 24.00K | 23.00K | 23.00K | 10.00K | 8.00K |
| Additional Paid-In Capital | 1.38B | 1.32B | 1.30B | 1.28B | 1.04B | 932.94M |
| Retained Earnings | -1.47B | -1.44B | -1.27B | -1.21B | -1.03B | -811.53M |
| Comprehensive Income & Other | -3.73M | -5.15M | 1.19M | -350.00K | -574.00K | 45.00K |
| Total Common Equity | -94.03M | -122.76M | 29.49M | 62.77M | 12.08M | 121.46M |
| Shareholders' Equity | -94.03M | -122.76M | 29.49M | 62.77M | 12.08M | 121.46M |
| Total Liabilities & Equity | 76.87M | 172.25M | 315.29M | 311.92M | 272.45M | 343.66M |
| Total Debt | 40.07M | 202.91M | 202.88M | 212.46M | 225.74M | 185.24M |
| Net Cash (Debt) | 16.96M | -65.97M | 91.64M | 83.96M | 29.94M | 139.98M |
| Net Cash Per Share | 5.35 | -23.10 | 32.40 | 44.01 | 28.32 | 149.63 |
| Filing Date Shares Outstanding | 6.11M | 2.93M | 2.84M | 2.82M | 1.19M | 946.99K |
| Total Common Shares Outstanding | 6.11M | 2.92M | 2.83M | 2.82M | 1.18M | 946.91K |
| Working Capital | -65.06M | 104.21M | 264.88M | 254.92M | 212.65M | 291.92M |
| Book Value Per Share | -15.39 | -42.03 | 10.41 | 22.28 | 10.23 | 128.27 |
| Tangible Book Value | -94.03M | -122.76M | 29.49M | 62.77M | 12.08M | 121.46M |
| Tangible Book Value Per Share | -15.39 | -42.03 | 10.41 | 22.28 | 10.23 | 128.27 |
| Machinery | 193.00K | 193.00K | 4.47M | 7.32M | 6.91M | |
| Construction In Progress | 83.00K | |||||
| Leasehold Improvements | 78.00K | 2.56M | 2.56M | 2.56M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -125.22M | -170.37M | -56.53M | -179.82M | -229.38M | -234.00M |
| Depreciation & Amortization | 931.00K | 1.00M | 4.15M | 4.38M | 4.43M | 5.17M |
| Other Amortization | 5.71M | 985.00K | 1.09M | 1.32M | 1.16M | 6.73M |
| Loss (Gain) From Sale of Assets | 806.00K | 726.00K | 20.00K | |||
| Asset Writedown & Restructuring Costs | 7.47M | 7.47M | 10.00M | 65.00K | 75.00K | |
| Loss (Gain) From Sale of Investments | -3.72M | -7.28M | -13.06M | -9.45M | -1.41M | 339.00K |
| Stock-Based Compensation | 14.33M | 10.55M | 20.62M | 28.52M | 42.55M | 32.01M |
| Change in Accounts Receivable | 1.47M | -6.89M | -5.34M | |||
| Change in Accounts Payable | 5.59M | -2.75M | -1.66M | 3.99M | -1.81M | -4.43M |
| Change in Unearned Revenue | -17.74M | -6.33M | 55.92M | |||
| Change in Other Net Operating Assets | -1.89M | 2.33M | -9.46M | -18.83M | -2.65M | 5.20M |
| Operating Cash Flow | -162.63M | -171.27M | -3.47M | -159.16M | -187.03M | -188.89M |
| Capital Expenditures | -79.00K | -410.00K | -1.55M | |||
| Sale (Purchase) of Intangibles | -65.00K | -75.00K | ||||
| Investment in Securities | 174.48M | 156.44M | 29.02M | -110.97M | -560.00K | -115.81M |
| Investing Cash Flow | 174.48M | 156.36M | 29.02M | -110.97M | -1.03M | -117.43M |
| Long-Term Debt Repaid | -12.58M | -11.61M | -5.81M | |||
| Net Debt Issued (Repaid) | -12.58M | -11.61M | -5.81M | |||
| Issuance of Common Stock | 6.34M | 6.42M | 629.00K | 201.77M | 122.90M | 3.33M |
| Other Financing Activities | -3.14M | 464.00K | ||||
| Financing Cash Flow | 3.19M | 6.42M | -11.49M | 190.15M | 117.09M | 3.33M |
| Foreign Exchange Rate Adjustments | -206.00K | 141.00K | -102.00K | 110.00K | -517.00K | -165.00K |
| Net Cash Flow | 14.84M | -8.34M | 13.96M | -79.86M | -71.49M | -303.15M |
| Free Cash Flow | -162.63M | -171.34M | -3.47M | -159.16M | -187.44M | -190.44M |
| Free Cash Flow Margin | -305.19% | -353.50% | -3.02% | |||
| Free Cash Flow Per Share | -51.29 | -59.98 | -1.23 | -83.43 | -177.30 | -203.56 |
| Levered Free Cash Flow | -29.76M | -93.33M | -16.70M | -84.66M | -99.55M | -99.82M |
| Unlevered Free Cash Flow | -28.62M | -87.45M | -10.59M | -77.54M | -92.04M | -94.40M |
| Cash Interest Paid | 10.07M | 10.00M | 10.56M | 12.29M | 12.71M | 12.74M |
| Change in Working Capital | -12.56M | -13.63M | 39.46M | -14.84M | -4.46M | 774.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 63.49M | 717.51M | 204.99M | 205.69M | 204.54M | 854.34M |
| Enterprise Value | 46.53M | 740.17M | 81.58M | 92.62M | 117.60M | 672.68M |
| Last Close Price | 10.38 | 248.00 | 72.37 | 73.00 | 173.60 | 904.80 |
| PS Ratio | 1.19 | 14.80 | 1.79 | |||
| PB Ratio | -5.84 | 6.95 | 3.28 | 16.94 | 7.03 | |
| P/TBV Ratio | 6.95 | 3.28 | 16.94 | 7.03 | ||
| EV/Sales Ratio | 0.87 | 15.27 | 0.71 | |||
| Debt / Equity Ratio | -0.43 | -1.65 | 6.88 | 3.38 | 18.69 | 1.52 |
| Net Debt / Equity Ratio | 0.18 | -0.54 | -3.11 | -1.34 | -2.48 | -1.15 |
| Net Debt / EBITDA Ratio | 0.11 | -0.40 | 1.55 | 0.49 | 0.14 | 0.65 |
| Net Debt / FCF Ratio | 0.10 | -0.39 | 26.42 | 0.53 | 0.16 | 0.73 |
| Asset Turnover | 0.34 | 0.20 | 0.37 | |||
| Quick Ratio | 0.46 | 2.36 | 6.67 | 5.75 | 5.19 | 8.16 |
| Current Ratio | 0.53 | 2.64 | 6.88 | 5.94 | 5.32 | 8.32 |
| Return on Equity (ROE) | -122.54% | -480.50% | -343.53% | -105.85% | ||
| Return on Assets (ROA) | -62.39% | -41.86% | -11.94% | -37.17% | -44.34% | -30.58% |
| Return on Capital Employed (ROCE) | 260.40% | -150.00% | -22.20% | -66.70% | -97.90% | -71.10% |
| Earnings Yield | -500.67% | -23.74% | -27.58% | -87.42% | -112.15% | -27.39% |
| FCF Yield | -256.15% | -23.88% | -1.69% | -77.38% | -91.64% | -22.29% |
| Buyback Yield / Dilution | -11.86% | -1.01% | -48.23% | -80.46% | -13.00% | -9.24% |